BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37756534)

  • 21. ISG15 uncut: Dissecting enzymatic and non-enzymatic functions of USP18 in vivo.
    Ketscher L; Knobeloch KP
    Cytokine; 2015 Dec; 76(2):569-571. PubMed ID: 25805508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity.
    Pinto-Fernandez A; Salio M; Partridge T; Chen J; Vere G; Greenwood H; Olie CS; Damianou A; Scott HC; Pegg HJ; Chiarenza A; Díaz-Saez L; Smith P; Gonzalez-Lopez C; Patel B; Anderton E; Jones N; Hammonds TR; Huber K; Muschel R; Borrow P; Cerundolo V; Kessler BM
    Br J Cancer; 2021 Feb; 124(4):817-830. PubMed ID: 33214684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ISG15-Protease USP18 Is a Pleiotropic Enhancer of HIV-1 Replication.
    Lin C; Kuffour EO; Li T; Gertzen CGW; Kaiser J; Luedde T; König R; Gohlke H; Münk C
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. USP18 promotes endometrial receptivity via the JAK/STAT1 and the ISGylation pathway.
    Zhang X; Gong S; Li H; Jiang J; Jia Y; Zhang R; Liu H; Wang A; Jin Y; Lin P
    Theriogenology; 2023 May; 202():110-118. PubMed ID: 36934584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free Interferon Stimulated Gene product-15 (ISG15).
    Gold IM; Reis N; Glaser F; Glickman MH
    Semin Cell Dev Biol; 2022 Dec; 132():16-26. PubMed ID: 35764457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical tools to define and manipulate interferon-inducible Ubl protease USP18.
    Davis GJ; Omole AO; Jung Y; Rut W; Holewinski R; Suazo KF; Kim HR; Yang M; Andresson T; Drag M; Yoo E
    bioRxiv; 2024 Apr; ():. PubMed ID: 38645224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin partly prevents ISG15 activation via ubiquitin-activating enzyme E1-like protein and decreases ISGylation.
    Oki N; Yamada S; Tanaka T; Fukui H; Hatakeyama S; Okumura F
    Biochem Biophys Res Commun; 2022 Oct; 625():94-101. PubMed ID: 35952613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis of the specificity of USP18 toward ISG15.
    Basters A; Geurink PP; Röcker A; Witting KF; Tadayon R; Hess S; Semrau MS; Storici P; Ovaa H; Knobeloch KP; Fritz G
    Nat Struct Mol Biol; 2017 Mar; 24(3):270-278. PubMed ID: 28165509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FOXO3a is stabilized by USP18-mediated de-ISGylation and inhibits TGF-β1-induced fibronectin expression.
    Wang B; Li Y; Wang H; Zhao J; Zhao Y; Liu Z; Ma H
    J Investig Med; 2020 Mar; 68(3):786-791. PubMed ID: 31874933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-stimulated gene 15 and the protein ISGylation system.
    Zhang D; Zhang DE
    J Interferon Cytokine Res; 2011 Jan; 31(1):119-30. PubMed ID: 21190487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation.
    Kim KI; Giannakopoulos NV; Virgin HW; Zhang DE
    Mol Cell Biol; 2004 Nov; 24(21):9592-600. PubMed ID: 15485925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth.
    Liu X; Lu Y; Chen Z; Liu X; Hu W; Zheng L; Chen Y; Kurie JM; Shi M; Mustachio LM; Adresson T; Fox S; Roszik J; Kawakami M; Freemantle SJ; Dmitrovsky E
    Mol Cancer Res; 2021 Apr; 19(4):667-677. PubMed ID: 33380466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. USP18 is an essential regulator of muscle cell differentiation and maturation.
    Olie CS; Pinto-Fernández A; Damianou A; Vendrell I; Mei H; den Hamer B; van der Wal E; de Greef JC; Raz V; Kessler BM
    Cell Death Dis; 2023 Mar; 14(3):231. PubMed ID: 37002195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection.
    Ritchie KJ; Hahn CS; Kim KI; Yan M; Rosario D; Li L; de la Torre JC; Zhang DE
    Nat Med; 2004 Dec; 10(12):1374-8. PubMed ID: 15531891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two independent mechanisms promote expression of an N-terminal truncated USP18 isoform with higher DeISGylation activity in the nucleus.
    Burkart C; Fan JB; Zhang DE
    J Biol Chem; 2012 Feb; 287(7):4883-93. PubMed ID: 22170061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target.
    Mustachio LM; Lu Y; Kawakami M; Roszik J; Freemantle SJ; Liu X; Dmitrovsky E
    Cancer Res; 2018 Feb; 78(3):587-592. PubMed ID: 29343520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ISG15 Deficiency Enhances HIV-1 Infection by Accumulating Misfolded p53.
    Osei Kuffour E; König R; Häussinger D; Schulz WA; Münk C
    mBio; 2019 Aug; 10(4):. PubMed ID: 31455647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Functional Roles of ISG15/ISGylation in Cancer.
    Yuan Y; Qin H; Li H; Shi W; Bao L; Xu S; Yin J; Zheng L
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36771004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetaldehyde Disrupts Interferon Alpha Signaling in Hepatitis C Virus-Infected Liver Cells by Up-Regulating USP18.
    Ganesan M; Poluektova LY; Tuma DJ; Kharbanda KK; Osna NA
    Alcohol Clin Exp Res; 2016 Nov; 40(11):2329-2338. PubMed ID: 27716962
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.